blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3377117

EP3377117 - SYSTEMS, METHODS, AND COMPOSITIONS FOR IMAGING ANDROGEN RECEPTOR AXIS ACTIVITY IN CARCINOMA, AND RELATED THERAPEUTIC COMPOSITIONS AND METHODS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.09.2023
Database last updated on 13.07.2024
FormerExamination is in progress
Status updated on  14.04.2020
FormerRequest for examination was made
Status updated on  24.08.2018
FormerThe international publication has been made
Status updated on  26.05.2017
Formerunknown
Status updated on  16.12.2016
Most recent event   Tooltip29.09.2023Application deemed to be withdrawnpublished on 01.11.2023  [2023/44]
Applicant(s)For all designated states
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065 / US
[2018/39]
Inventor(s)01 / ULMERT, David
c/o Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, New York 10065 / US
 [2018/39]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2018/39]Holland, David Christopher
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date16806415.218.11.2016
[2018/39]
WO2016US62818
Priority number, dateUS201562257179P18.11.2015         Original published format: US 201562257179 P
[2018/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017087826
Date:26.05.2017
Language:EN
[2017/21]
Type: A1 Application with search report 
No.:EP3377117
Date:26.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.2017 takes the place of the publication of the European patent application.
[2018/39]
Search report(s)International search report - published on:EP26.05.2017
ClassificationIPC:A61K49/00, A61K51/10, A61K31/568, A61K31/57, C07K16/30, A61P35/00, A61K103/40, A61K103/00
[2018/39]
CPC:
A61K51/1051 (EP,US); A61K31/568 (EP,US); A61K31/57 (EP,US);
A61K49/0032 (EP,US); A61K49/0058 (EP,US); A61K51/1072 (EP,US);
A61K51/1093 (EP,US); A61K51/1096 (EP,US); A61P35/00 (EP);
C07K16/3015 (EP,US); C07K16/3069 (EP,US); A61K2039/505 (EP,US);
C07K2317/24 (EP,US); C07K2317/526 (EP,US); C07K2317/71 (EP,US);
C07K2317/77 (EP,US); C07K2317/90 (EP,US); C07K2317/92 (EP,US) (-)
C-Set:
A61K31/568, A61K2300/00 (US,EP);
A61K31/57, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/39]
TitleGerman:SYSTEME, VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ABBILDUNG DER ANDROGENREZEPTORACHSENAKTIVITÄT IM KARZINOM UND ENTSPRECHENDE THERAPEUTISCHE ZUSAMMENSETZUNGEN UND VERFAHREN[2018/39]
English:SYSTEMS, METHODS, AND COMPOSITIONS FOR IMAGING ANDROGEN RECEPTOR AXIS ACTIVITY IN CARCINOMA, AND RELATED THERAPEUTIC COMPOSITIONS AND METHODS[2018/39]
French:SYSTÈMES, MÉTHODES ET COMPOSITIONS POUR L'IMAGERIE DE L'ACTIVITÉ DE L'AXE DU RÉCEPTEURS DES ANDROGÈNES DANS UN CARCINOME, ET COMPOSITIONS ET MÉTHODES THÉRAPEUTIQUES ASSOCIÉES[2018/39]
Entry into regional phase15.06.2018National basic fee paid 
15.06.2018Designation fee(s) paid 
15.06.2018Examination fee paid 
Examination procedure15.06.2018Examination requested  [2018/39]
15.06.2018Date on which the examining division has become responsible
07.01.2019Amendment by applicant (claims and/or description)
17.04.2020Despatch of a communication from the examining division (Time limit: M06)
26.10.2020Reply to a communication from the examining division
01.06.2023Application deemed to be withdrawn, date of legal effect  [2023/44]
22.06.2023Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2023/44]
Fees paidRenewal fee
15.06.2018Renewal fee patent year 03
14.11.2019Renewal fee patent year 04
13.11.2020Renewal fee patent year 05
21.10.2021Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.202207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2013063312  (SLOAN KETTERING INST CANCER [US]) [X] 1,3-6,8,10-16,18,19,22,24-26,28,30,32,41,43,48,50 * examples 1-6 * * paragraph [0097] - paragraph [0105] *;
 [XA]WO2015075445  (FREDAX AB [SE], et al) [X] 41,43,48,50 * examples 1-9 * * page 18, line 7 - line 20 * * page 31, line 8 - line 11 * [A] 1-40,42,44-47,49,51,52;
 [E]WO2016191186  (MEMORIAL SLOAN KETTERING CANCER CENTER [US]) [E] 35-52 * paragraph [0136] - paragraph [0144] *;
 [A]  - LE BEAU A M ET AL, "Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, vol. 73, no. 7, doi:10.1158/0008-5472.CAN-12-3526, ISSN 0008-5472, (20130401), pages 2070 - 2081, (20130211), XP009170198 [A] 1-52 * abstract * * page 8, column 2, paragraph 2 - page 10, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-12-3526
by applicantUS8663600
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.